SCHEMBL6023455

SCHEMBL6023455

CC(=O)C(CCCc1ccccc1)n1cnc2c(=O)[nH]c(Cc3ccc(Cl)c(OC(F)F)c3)nc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 5/20 0.43
▸ RNASEH1 O60930 1/20 0.34
▸ CCNE2 O96020 8/20 0.33
▸ CCNE1 P24864 8/20 0.33
▸ CDK2 P24941 8/20 0.33
▸ CDK4 P11802 6/20 0.33
▸ CCND1 P24385 6/20 0.33
▸ CCNB2 O95067 4/20 0.33
▸ CDK1 P06493 4/20 0.33
▸ CCNB1 P14635 4/20 0.33
▸ CCNB3 Q8WWL7 4/20 0.33
▸ PDE5A O76074 1/20 0.33
▸ PDE9A O76083 1/20 0.33
▸ PDE1A P54750 1/20 0.33
▸ PDE1B Q01064 1/20 0.33
▸ PDE1C Q14123 1/20 0.33
▸ CCNK O75909 1/20 0.33
▸ CCND3 P30281 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ CDK7 P50613 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6024717 0.91 PDE2A (0.46) PDE2ARNASEH1CCNE2CCNE1CDK2
SCHEMBL6024368 0.91 PDE2A (0.46) PDE2ARNASEH1CCNE2CCNE1CDK2
SCHEMBL6023491 0.90 PDE2A (0.44) PDE2ARNASEH1PDE9APDE1APDE1B
SCHEMBL6023263 0.88 PDE2A (0.44) PDE2ARNASEH1
SCHEMBL6024017 0.87 PDE2A (0.41) PDE2ARNASEH1PDE9APDE1APDE1B
SCHEMBL359546 0.86 PDE2A (0.51) PDE2ARNASEH1CCNE2CCNE1CDK2
SCHEMBL6024990 0.85 PDE2A (0.38) PDE2APDE5APDE4APDE4BPDE4C
SCHEMBL7442320 0.83 PDE2A (0.52) PDE2ARNASEH1CCNE2CCNE1CDK2
SCHEMBL6023286 0.82 PDE2A (0.37) PDE2ARNASEH1PDE5A
SCHEMBL6023285 0.82 PDE2A (0.38) PDE2APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060106037-A1 Purin-6-one-derivatives ALTANA PHARMA AG (DE) 2006-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106037-A1 Purin-6-one-derivatives PDE4B, PDE4A, PDE2A PDE2A 3/4885RNASEH1 450/4885CCNE2 3084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback